NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation.

In KIRP, KIPAN, LIHC, LGG, LAML, LUAD, MESO, PAAD, ACC and KICH, OS showed a decreasing trend with higher NCAPG2 expression ( Figure S1 ), as did the KM curves of DSS in LGG, LUAD, KIRP, KIPAN, LIHC, SKCM, BLCA, MESO, PAAD, ACC and KICH, while in READ and THYM it was accompanied by a higher OS ( Figure S2 ).

also in 47,180 other papers

Notably, although no statistical significance was observed in tumors like LGG, MESO, CHOL, PAAD, an overall trend could be noticed that NCAPG2 is inclined to manifest a specific elevation in advanced tumors, which highlights the prognostic value of NCAPG2 to some extent.

also in 4,871 other papers